Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs
暂无分享,去创建一个
Klaas Schildknegt | Douglas K Spracklin | Hongying Gao | L. Tremaine | R. Obach | A. Vaz | Hongying Gao | Sharon L Ripp | R Scott Obach | Alfin D N Vaz | Raman Sharma | S. Ripp | K. Schildknegt | Larry M Tremaine | Timothy J Strelevitz | Alan J Clark | Raman K. Sharma | T. J. Strelevitz | D. K. Spracklin | R. S. Obach | Alan J. Clark | Sharon L. Ripp | Alfin D. N. Vaz
[1] R. Dempski,et al. The Reductive Half-reaction of Xanthine Oxidase , 1999, The Journal of Biological Chemistry.
[2] C. Beedham,et al. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon. , 1995, Archives of biochemistry and biophysics.
[3] A. B. Foster. Deuterium isotope effects in studies of drug metabolism , 1984 .
[4] F. Schneider,et al. Enhanced Plasma Concentration by Selective Deuteration of Rofecoxib in Rats , 2006, Arzneimittelforschung.
[5] R. Hanzlik,et al. Kinetic deuterium isotope effects on the N-demethylation of tertiary amides by cytochrome P-450. , 1990, The Journal of biological chemistry.
[6] R. Hanzlik,et al. Deuterium isotope effects on toluene metabolism. Product release as a rate-limiting step in cytochrome P-450 catalysis. , 1989, Biochemical and biophysical research communications.
[7] N. Vermeulen,et al. Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: A study in healthy volunteers , 1988, Biopharmaceutics & drug disposition.
[8] Editor-in-Chief R. Seifert,et al. Naunyn-Schmiedeberg's archives of pharmacology , 2005, Klinische Wochenschrift.
[9] R. Obach,et al. Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences , 2010, Drug Metabolism and Disposition.
[10] Deepak Dalvie,et al. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites. , 2009, Chemical research in toxicology.
[11] Bryan M. Li,et al. Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections. , 2009, Journal of medicinal chemistry.
[12] A. Y. Lu,et al. Kinetic isotope effects and ‘metabolic switching’ in cytochrome P450‐catalyzed reactions , 1987, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] D. Kushner,et al. Pharmacological uses and perspectives of heavy water and deuterated compounds. , 1999, Canadian journal of physiology and pharmacology.
[14] F. Guengerich,et al. Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid via Acetaldehyde* , 1999, The Journal of Biological Chemistry.
[15] T. Naruke,et al. Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[16] A. Boulton,et al. Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.
[17] J. Sahi,et al. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human. , 2008, Drug metabolism letters.
[18] C. Beedham,et al. Species variation in hepatic aldehyde oxidase activity , 1987, European Journal of Drug Metabolism and Pharmacokinetics.
[19] J. Reid,et al. A species difference in the presystemic metabolism of carbazeran in dog and man. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.
[20] L. Pohl,et al. Determination of toxic pathways of metabolism by deuterium substitution. , 1984, Drug metabolism reviews.
[21] J. Cano,et al. Human hepatocytes as a keyin vitro model to improve preclinical drug development , 1990, European Journal of Drug Metabolism and Pharmacokinetics.
[22] W. Trager,et al. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[23] B. Belleau,et al. Effect of Deuterium Substitution in Sympathomimetic Amines on Adrenergic Responses , 1961, Science.
[24] Y. Moriwaki,et al. Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies , 2005, Histochemistry and Cell Biology.
[25] Deepak Dalvie,et al. Aldehyde oxidase: an enzyme of emerging importance in drug discovery. , 2010, Journal of medicinal chemistry.
[26] M. Fratelli,et al. Mammalian aldehyde oxidases: genetics, evolution and biochemistry , 2008, Cellular and Molecular Life Sciences.
[27] J. Paxton,et al. Inter-species variation in the metabolism and inhibition of N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase. , 2000, Biochemical pharmacology.
[28] M. Monshouwer,et al. In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor , 2011, The Pharmacogenomics Journal.
[29] E. Pettersen,et al. The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-d1-d-glucose in mice and rats , 2004, Cancer Chemotherapy and Pharmacology.
[30] S. Kitamura,et al. Drug-metabolizing ability of molybdenum hydroxylases. , 2006, Drug metabolism and pharmacokinetics.
[31] S. Wrighton,et al. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[32] Y. Moriwaki,et al. Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining. , 2001, Histology and histopathology.
[33] M. Blake,et al. EFFECTS OF DEUTERATION ON LOCOMOTOR ACTIVITY OF AMPHETAMINE , 1978 .
[34] Jeffrey P. Jones,et al. Studies on the mechanism of aldehyde oxidase and xanthine oxidase. , 2008, The Journal of organic chemistry.
[35] F. Schneider,et al. Changed Phosphodiesterase Selectivity and Enhanced in vitro Efficacy by Selective Deuteration of Sildenafil , 2007, Arzneimittelforschung.
[36] C. Ioannides,et al. Effect of deuteration of imipramine on its pharmacokinetic properties in the rat. , 1983, Biochemical pharmacology.
[37] D. Newell,et al. The metabolism of deuterated analogues of chlorambucil by the rat. , 1979, Chemico-biological interactions.